Cargando…
Epigenetic biomarker screening by FLIM-FRET for combination therapy in ER+ breast cancer
Hormone-dependent gene expression involves dynamic and orchestrated regulation of epigenome leading to a cancerous state. Estrogen receptor (ER)-positive breast cancer rely on chromatin remodeling and association with epigenetic factors in inducing ER-dependent oncogenesis and thus cell over-prolife...
Autores principales: | Liu, Wenjie, Cui, Yi, Ren, Wen, Irudayaraj, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354376/ https://www.ncbi.nlm.nih.gov/pubmed/30700309 http://dx.doi.org/10.1186/s13148-019-0620-6 |
Ejemplares similares
-
Dynamic FRET-FLIM based screening of signal transduction pathways
por: Harkes, Rolf, et al.
Publicado: (2021) -
Molecular determinants of ER–Golgi contacts identified through a new FRET–FLIM system
por: Venditti, Rossella, et al.
Publicado: (2019) -
Practical and reliable FRET/FLIM pair of fluorescent proteins
por: Shcherbo, Dmitry, et al.
Publicado: (2009) -
FLIM-FRET analyzer: open source software for automation of lifetime-based FRET analysis
por: Kim, Jiho, et al.
Publicado: (2017) -
Quantitative analysis of chromatin compaction in living cells using FLIM–FRET
por: Llères, David, et al.
Publicado: (2009)